TipRanks
Argenica Therapeutics Ltd (AU:AGN)
ASX:AGN
Australian Market
AGN
Argenica Therapeutics Ltd
RESEARCH TOOLSreports
Want to see AU:AGN full AI Analyst Report?

Argenica Therapeutics Ltd (AGN) Ratios

14 Followers

Argenica Therapeutics Ltd Ratios

AU:AGN's free cash flow for Q4 2026 was AU$0.00. For the 2026 fiscal year, AU:AGN's free cash flow was decreased by AU$ and operating cash flow was AU$0.00. See a summary of the company’s cash flow.
Ratios
TTM
Jun 26Jun 25Jun 24Jun 23
Liquidity Ratios
Current Ratio
 10.60 10.60 2.90 6.75 5.09
Quick Ratio
 10.60 10.60 2.90 6.75 5.09
Cash Ratio
 10.35 10.35 2.78 6.56 4.96
Solvency Ratio
 -2.22 -2.22 0.13 0.08 0.03
Operating Cash Flow Ratio
 -6.82 -6.82 -1.50 -2.09 -1.76
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
AU$ 5.90MAU$ 5.90MAU$ 7.24MAU$ 13.95MAU$ 7.67M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.10 1.10 1.53 1.17 1.24
Debt Service Coverage Ratio
 0.00 0.00 0.00 0.00 -3.27K
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 -6.31K
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 0.00 0.00 0.00 0.00 <0.01
Net Debt to EBITDA
 0.90 0.90 0.00 8.39 1.93
Profitability Margins
Gross Profit Margin
0.00%0.00%100.00%100.00%0.00%
EBIT Margin
0.00%0.00%-239.05%-291.34%0.00%
EBITDA Margin
0.00%0.00%0.00%-73.04%0.00%
Operating Profit Margin
0.00%0.00%-239.05%-218.30%0.00%
Pretax Profit Margin
0.00%0.00%-223.11%-291.34%0.00%
Net Profit Margin
0.00%0.00%-223.11%-210.92%0.00%
Continuous Operations Profit Margin
0.00%0.00%-223.11%-210.92%0.00%
Net Income Per EBT
25.57%25.57%100.00%72.40%77.75%
EBT Per EBIT
75.62%75.62%93.33%133.46%93.48%
Return on Assets (ROA)
-20.95%-20.95%-64.95%-33.46%-50.47%
Return on Equity (ROE)
-29.22%-23.13%-99.08%-39.28%-62.81%
Return on Capital Employed (ROCE)
-119.63%-119.63%-106.15%-40.65%-86.41%
Return on Invested Capital (ROIC)
-30.59%-30.59%-106.15%-29.43%-67.19%
Return on Tangible Assets
-20.95%-20.95%-64.96%-33.46%-50.47%
Earnings Yield
-7.59%-11.07%-7.40%-7.02%-14.66%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 7.63 6.98 0.00
Payables Turnover
 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 0.00 0.00 0.29 0.16 0.00
Working Capital Turnover Ratio
 0.00 0.00 0.30 0.24 0.00
Cash Conversion Cycle
 0.00 0.00 47.87 52.28 0.00
Days of Sales Outstanding
 0.00 0.00 47.87 52.28 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 0.00 0.00 0.00 0.00 0.00
Operating Cycle
 0.00 0.00 47.87 52.28 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.03 -0.03 -0.04 -0.05 -0.04
Free Cash Flow Per Share
 -0.03 0.00 -0.04 -0.05 -0.04
CapEx Per Share
 0.00 0.03 <0.01 0.00 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 0.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 0.00 -1.00 -1.90M 0.00 -825.08K
Capital Expenditure Coverage Ratio
 0.00 -1.00 -1.90M 0.00 -825.08K
Operating Cash Flow Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
 0.00 0.00 -1.77 -1.95 0.00
Free Cash Flow Yield
-23.30%0.00%-5.89%-6.48%-10.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -13.21 -9.06 -13.52 -14.25 -6.82
Price-to-Sales (P/S) Ratio
 0.00 0.00 30.16 30.05 0.00
Price-to-Book (P/B) Ratio
 3.05 2.09 13.39 5.60 4.28
Price-to-Free Cash Flow (P/FCF) Ratio
 -4.29 0.00 -16.99 -15.42 -9.95
Price-to-Operating Cash Flow Ratio
 -4.29 -2.94 -16.99 -15.42 -9.95
Price-to-Earnings Growth (PEG) Ratio
 -0.72 0.11 -2.24 3.92 12.57
Price-to-Fair Value
 3.05 2.09 13.39 5.60 4.28
Enterprise Value Multiple
 -1.65 -0.85 0.00 -32.75 -4.89
Enterprise Value
 11.62M 5.97M 86.36M 62.14M 23.55M
EV to EBITDA
 -1.65 -0.85 0.00 -32.75 -4.89
EV to Sales
 0.00 0.00 26.87 23.92 0.00
EV to Free Cash Flow
 -2.77 0.00 -15.14 -12.28 -7.14
EV to Operating Cash Flow
 -2.77 -1.42 -15.14 -12.28 -7.14
Tangible Book Value Per Share
 0.05 0.05 0.06 0.13 0.09
Shareholders’ Equity Per Share
 0.05 0.05 0.06 0.13 0.09
Tax and Other Ratios
Effective Tax Rate
 0.74 0.74 0.00 0.28 0.22
Revenue Per Share
 0.00 0.00 0.03 0.03 0.00
Net Income Per Share
 -0.01 -0.01 -0.06 -0.05 -0.05
Tax Burden
 0.26 0.26 1.00 0.72 0.78
Interest Burden
 0.76 0.76 0.93 1.00 1.00
Research & Development to Revenue
 0.00 0.00 2.53 2.32 0.00
SG&A to Revenue
 0.00 0.00 0.86 0.33 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.03 0.05 0.00
Income Quality
 3.07 3.07 0.80 0.92 0.69
Currency in AUD